Immunologic Analysis of a Spinal Cord–Biopsy Specimen from a Patient with Human T-Cell Lymphotropic Virus Type I–Associated Neurologic Disease

Michael C. Levin, Tanya Lehky, Alfred N. Flerlage, David Katz, Douglas W. Kingma, Elaine S. Jaffe, John D. Heiss, Nicholas J. Patronas, Henry F. McFarland, Steven Jacobson

New England Journal of Medicine · 1997 · 80 citations · 25 references

Concepts

Abstract

Human T-cell lymphotropic virus type I (HTLV-I) is associated with adult T-cell leukemia and a chronic progressive neurologic disease, HTLV-I–associated myelopathy–tropical spastic paraparesis (hereafter referred to as HTLV-I–associated myelopathy).1–5 HTVL-I is endemic in Japan, the Caribbean, Africa, and South America.5 Risk factors for infection include sexual contact, exchange of blood products, and vertical transmission from mother to child.5 HTLV-I–associated myelopathy causes progressive myelopathy with atrophy of the spinal cord.5,6 Subcortical white-matter lesions are sometimes present on magnetic resonance imaging.5–7 Cerebrospinal fluid shows pleocytosis, elevated titers of IgG, and oligoclonal bands.8–10 Autopsy results correlate with neurologic findings . . .

References

25